Valneva SE
NASDAQ:VALNBiotechnology
+$0.01 today
- Market cap
- $507.98M
- Beta
- 1.40
- P/E (TTM)
- -2.9
- EPS (TTM)
- -$0.80
Volume 0.00M
Average 0.09M
VALN Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
Valneva SENASDAQ: VALN
Change in Working Capital · Q1 FY2026 · quarter ended Mar 2026
Change in working capital turns positive
Q1 FY2026 change in working capital was €17.22M, compared with -€8.77M a year earlier. Trailing-twelve-month change in working capital was €25.29M. Over 3 fiscal years it compounded at -90.0% a year.
Context
- Change in working capital amounted to 0.1% of revenue in FY2025, down 6.7 pp from a year earlier.
- Change in working capital grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly change in working capital holds near €17.22M or moves back toward the trailing-twelve-month quarterly average of €6.32M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Change in Working Capital history
EUR · from the cash flow
- Latest · FY2025
- (148K) EUR
- Year-over-year change
- +98.7%
| Period | Period end | Change in Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (148K) | +98.7% |
| FY2024 | 2024-12-31 | (11.57M) | +92.0% |
| FY2023 | 2023-12-31 | (145.06M) | +0.6% |
| FY2022 | 2022-12-31 | (145.98M) | -504.1% |
| FY2021 | 2021-12-31 | 36.13M | — |
Change in Working Capital vs competitors
How VALN compares with its peers on the latest reported figures
- Peers report in different currencies, so change in working capital is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +212.0% is the highest of 8, against a peer median of -85.7%.
- Change in working capital amounts to 16.2% of revenue for VALN, versus a peer median of 18.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $204M USD | -50.4% | — | 8.1% | |
| LTM Mar 2026 | $173.12M USD | -76.1% | +35.0% | 29.0% | |
| LTM Mar 2026 | $71.19M USD | -394.2% | — | 108.7% | |
| LTM Mar 2026 | €25.29M EUR | +212.0% | -90.0% | 16.2% | |
| LTM Mar 2026 | $8.51M USD | -85.7% | +46.2% | 18.8% | |
| LTM Sep 2026 | $6.11M USD | -88.0% | +50.3% | 3.3% | |
| LTM Mar 2026 | $5.96M USD | -9.5% | — | — | |
| LTM Jun 2026 | $702K USD | -106.4% | — | — | |
| Peer median (excluding VALN) | — | -85.7% | +46.2% | 18.8% | |
Competitors are the stored peer set for VALN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (73.43M) | (143.28M) | (101.43M) | (12.25M) | (115.19M) |
| Depreciation & Amortization | 14.28M | 21.04M | 17.58M | 19.59M | 21.75M |
| Deferred Income Tax | 3.45M | (1.54M) | 2.8M | 761K | 1.07M |
| Stock-Based Compensation | 14.51M | (8.66M) | 5.11M | 7.98M | 9.53M |
| Change in Working Capital | 36.13M | (145.98M) | (145.06M) | (11.57M) | (148K) |
| Accounts Receivables | (21.35M) | 12.4M | (2.86M) | 15.71M | 13.33M |
| Inventory | (92.37M) | 84.22M | (9.17M) | (6.8M) | 1.03M |
| Accounts Payables | 35.24M | (14.05M) | (17.4M) | 0 | 0 |
| Other Working Capital | 114.61M | (228.55M) | (115.65M) | (20.48M) | (14.51M) |
| Other Non-Cash Items | 81.96M | 33.07M | 18.25M | (71.72M) | 30.09M |
| Operating Cash Flow | 76.9M | (245.34M) | (202.74M) | (67.22M) | (52.89M) |
| Capital Expenditures | (93.17M) | (29.32M) | (14.31M) | (16.44M) | (4.48M) |
| Acquisitions (Net) | 0 | 8K | (10.95M) | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 841K |
| Other Investing Activities | 55K | 260K | 4.6M | 90.78M | 1.87M |
| Investing Cash Flow | (93.12M) | (29.05M) | (20.59M) | 76.92M | (1.71M) |
| Debt Repayment | (3.9M) | 34.49M | 75.89M | (6.49M) | 61K |
| Common Stock Issued | 166.82M | 189.84M | 0 | 0 | 30M |
| Common Stock Repurchased | 0 | 0 | (240K) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (8.42M) | (9.21M) | (12.57M) | (19.97M) | (30.69M) |
| Financing Cash Flow | 154.5M | 215.12M | 63.08M | 30.68M | (621K) |
| Effect of Forex Changes | 3.96M | (828K) | (204K) | 1.81M | (3.4M) |
| Net Change in Cash | 142.29M | (57.21M) | (160.45M) | 42.19M | (58.62M) |
| Free Cash Flow | (16.27M) | (274.67M) | (217.06M) | (83.66M) | (57.38M) |
Valneva SE
NASDAQ:VALN
Intrinsic Alpha fair value
Locked
Current Price
$5.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.